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 Maintaining deciduous teeth in function until their natural exfoliation is absolutely 
necessary. Vital pulp therapy (VPT) is a way of saving deciduous teeth. The most important 
factors in success of VPT are the early diagnosis of pulp and periradicular status, 
preservation of the pulp vitality and proper vascularization of the pulp. Development of 
new biomaterials with suitable biocompatibility and seal has changed the attitudes towards 
preserving the reversible pulp in cariously exposed teeth. Before exposure and irreversible 
involvement of the pulp, indirect pulp capping (IPC) is the treatment of choice, but after 
the spread of inflammation within the pulp chamber and establishment of irreversible 
pulpitis, removal of inflamed pulp tissue is recommended. In this review, new concepts in 
preservation of the healthy pulp tissue in deciduous teeth and induction of the reparative 
dentin formation with new biomaterials instead of devitalization and the consequent 
destruction of vital tissues are discussed. 
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Introduction 
remature loss of primary teeth can lead to malocclusion 
besides functional and esthetic problems. Therefore, 
preserving the vitality of deciduous teeth until their natural 
exfoliation time is critical for maintaining the arch integrity. The 
pulp in primary dentition is histologically similar to permanent 
teeth and may be affected by caries, restorative procedure and 
trauma. Depending on severity of injury; the reaction of pulp is 
different [1]. However, this similarity is not applicable when pulp 
reaction to irritants is concerned [2]. Accepted endodontic 
therapy for primary teeth can be divided into two main 
categories: vital pulp therapy (VPT) and root canal treatment 
(RCT). The primary objectives of VPT in deciduous teeth are 
treating reversible pulpal injuries and maintaining pulp 
vitality/function. Several factors such as adequate blood supply, 
severity of inflammation, obtaining homeostasis, disinfection of 
the exposure site, antibacterial properties and biocompatibility of 
pulp covering agents and adequate coronal seal may affect the 
success of VPT. The most important factor in success of VPT is 
vitality of the pulp and, in particular, the presence of proper 
vascularization, which is necessary for active formation/function 
of the odontoblasts. 
VPT includes three therapeutic approaches: indirect pulp 
capping (IDPC) for teeth with dentinal cavities and reversible 
pulpitis; direct pulp capping (DPC) and pulpotomy [1] which 
are considered in cases of pulp exposure. This review intended 
to provide information on different approaches of VPT for 
primary teeth. 
Indirect pulp capping (IDPC) 
IDPC is recommended for teeth with deep carious lesions 
approximating the pulp but there are no signs or symptoms of 
pulp degeneration. In this procedure, the deepest layer of the 
remaining carious dentine is covered with biocompatible 
materials [1]. 
Several medicaments are advocated for IDPC such as 
mineral trioxide aggregate (MTA) [3], medical Portland 
cement (PC) [3], calcium hydroxide (CH) [4], resin modified 
glass ionomer (RMGI) [5, 6], dentin bonding agents [4] and 
bioactive molecules such as enamel matrix protein (Emdogain) 
or members of bone morphogenic protein (BMP) super family 
such as tissue growth factor-β (TGF-β) [1]. 
The rationale for IDPC is that few viable bacteria remain 
in the deeper dentine layers and after the cavity has been 
seated properly, they will be inactivated. Based on the clinical 
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studies that looked precisely at the partial caries removal and 
residual bacteria, there was a dramatic reduction in the 
colony forming units (CFU) of bacteria regardless of using 
either zinc oxide-eugenol (ZOE) or CH on the remaining 
carious lesion. This result focuses on the importance of cavity 
seal and may negate the need for re-entry in these cases unless 
symptoms prevail [7]. 
Success rate of IDPC have been reported to be higher than 
90% in primary teeth [8, 9]. Several studies reported the success 
rate of IDPC with different agents in primary teeth which are 
summarized in Table 1. 
According to the growing evidence about the success rate of 
IDPC in deciduous teeth, this treatment approach can be 
recommend as an appropriate strategy for symptom-free 
primary teeth with deep carious lesions provided that a proper 
leakage-free restoration can be placed. 
Direct pulp capping (DPC) 
Direct pulp capping (DPC) is carried out when a healthy pulp 
has been mechanically/accidentally exposed during operative 
procedures or trauma. The injured tooth must be 
asymptomatic and the exposure site must be pinpoint in 
diameter and free of oral contaminants [1]. DPC involves the 
application a bioactive dental material on the exposed pulp in 
an attempt to preserve its vitality [10]. The rationale behind 
this treatment is to stimulate the pulp to initiate reparative 
tertiary dentine formation at the exposure site [11]. 
DPC of primary teeth is one of the most controversial 
treatment methods. The success rate of this method is not 
particularly high for deciduous teeth [1]. The undifferentiated 
mesenchymal cells which may differentiate into odontoclasts 
leading to internal resorption, are responsible for high failure 
rate of this treatment [1]. 
Several medicaments have been introduced for DPC 
including: CH [12, 13], ZOE cement [14], formocresol (FC) 
[12], polycarboxylate cement [14], dentine adhesives, enamel 
matrix derivative (EMD) [13], MTA [11, 15, 16], calcium-
enriched mixture (CEM) cement [14] and simvastatin [17]. 
Some of the medicaments which present better results in trails 
are indicated in Table 2. 
Although guidelines published by the American Academy 
of Pediatric Dentistry (AAPD) do not recommend DPC for 
caries exposed primary teeth [18], promising results (over 90% 
success) of recent clinical trials [11, 14, 17] may challenge this 
policy in the future. 
Pulpotomy 
Pulpotomy is one of the most widely accepted clinical 
procedures for treating cariously exposed pulps in symptom-
free primary teeth. The rationale is based on the healing ability 
of the radicular pulp tissue following surgical amputation of 
the affected or infected coronal pulp [1]. 
Pulpotomy can be performed using different techniques 
including non-pharmacotherapeutic treatments such as 
electrosurgery (ES) [19] and laser [20-22] or pharmacotherapeutic 
approaches by dressing the pulp tissue with different medicaments 
or biological materials such as FC [23, 24], gultaraldehyde (GA) 
[25], ferric sulfate (FS) [26, 27], CH [28, 29], MTA [30, 31], freeze-
dried bone [32], bone morphogenic protein (BMP) [33], 
osteogenic protein [34], sodium hypochlorite (NaOCl) [35, 36], 
CEM cement [37], enriched collagen solutions [38], PC [39] and 
fully synthetic nanocrystalline hydroxyapatite paste [40]. 
Pulpotomy also can be classified according to the following 
treatment objectives: devitalization (mummification, 
cauterization), preservation (minimal devitalization, 
noninductive) or regeneration (inductive, reparative) [41]. 
 
Table 1. Variable success rates with different indirect pulp capping (IDPC) agents (CHX=chlorhexidine, RMGI=resin modified glass ionomer, 
PC=Portland cement, CH=calcium hydroxide, GI=glass ionomer) 
Author, year IDPC medicament Success (%) Follow-up (month) 
Sample size (n) 
Baseline Final 
Rosenberg et al. (2013) [42] CHX and RMGI 97 12 60 32 




PC 90.3 13 9 
CH 90.3 14 10 




3 MIX antibiotic 78 41 37 
Arizos and Kotsanos (2011) [5] RMGI 96.5 31 90 86 
Gruythuysen et al. (2010) [6] RMGI 96 36 125 86 
Casagrande et al. (2009) [44] 
Total etch adhesive 93 60 25 15 
CH 80 60 23 10 
Franzon et al. (2007) [45] 
CH 73.3 
36 19 15 
Gutta-percha 85.7 




RMGI 93.3 15 15 
Vij et al. (2004) [8] GI 94 40 108 108 
Al-Zayer et al. (2003) [9] CH 95 14 187  
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Although a considerable number of clinical trials with different 
techniques and materials have been performed and published 
about pulpotomy in primary teeth, a Cochrane review found 
that evidence is lacking to conclude which is the most 
appropriate technique for pulpotomies in primary teeth [47]. 
Among those biological materials and medicaments which 
were mentioned earlier, some of them are widely accepted and 
showed good clinical and radiographic success rates which will 
be discussed considering the treatment-objective classification. 
Devitalization 
The first approach in pulpotomy of deciduous teeth is 
devitalization, where the vital pulp tissue is destroyed. It 
includes pulpotomy with FC, GA, ES and laser. 
Formocresol: FC has been a popular pulpotomy medicament in 
the deciduous teeth for the last 70 years, since its introduction by 
Sweet in 1932 [48]. The success rate of FC pulpotomy is reported 
to be 70-98%. FC consists of 19% formaldehyde, 35% cresol in a 
vehicle of 15% glycerin and water (Buckley's solution) [36]. FC 
prevents tissue autolysis by bonding to protein; Berger [49] 
described the histological view of pulp tissue following FC 
pulpotomy. Fixation of the pulp occurred in coronal third of the 
root, the middle third presented loss of cellular integrity and 
apical third showed granulation tissue growth. Although 
concerns have been raised about safety (i.e. mutagenicity, 
carcinogenicity and immune sensitization potential) of FC 
application in human [37], no correlation between FC 
pulpotomies and cancer has ever been demonstrated [38]. 
Gultaraldehyde: GA was introduced to dentistry in 1979 by 
Kopel [41]. It has been suggested as an alternative to FC as a 
pulpotomy agent based on its superior fixative properties, low 
antigenicity and low toxicity. GA causes rapid surface fixation 
of the underlying pulpal tissue. A narrow zone of eosinophillic, 
stain and compressed fixed tissue is found directly beneath the 
site of application, which blends into vital normal appearing 
tissue apically [41].  
In a recent study by Havale et al. [50] the relative clinical and 
radiographic success of FC, GA and FS pulpotomies were  
compared at three-month intervals over one year. The clinical 
success rates of FC, FS and GA were 86.7, 96.7 and 100%, 
respectively. The radiographic success rates gradually decreased 
over the year in all pulpotomy groups and the radiographic 
success rates in FC, GA and FS were 56.7, 83.3 and 63.3%, 
respectively. Therefore, 2% GA may be recommended as an 
alternative to FC pulpotomy. 
In the other clinical study by Tsai et al. [51], the clinical and 
radiographic success rates of 5% buffered GA were 98 and 87.5%, 
respectively. But the relative high failure rate in this long-term 
follow-up indicated that clinicians should be cautions before 
extensively using GA as a pulpotomy agent. 
Electrosurgery: ES is a non-pharmacological homeostatic 
technique which has been suggested for the pulpotomy 
procedure. It involves cutting and coagulating soft tissues by 
means of high-frequency electric current passing through the 
tissue cells [52]. This technique carbonizes and heat denatures 
the pulp and bacterial contamination. ES pulpotomy seems to 
have great merits. The self-limiting pulpal penetration is only a 
few cell layers deep. There is good visualization and homeostasis 
without chemical coagulation or systemic involvement. 
Spending less chair time in this technique than the FC 
pulpotomy is another benefit [27]. 
In a randomized clinical trial by Bahrololoomi et al. [53] no 
significant difference between ES and FC pulpotomies in primary 
molars were reported [53]. In another randomized clinical trial 
Dean et al. [19] found that there was not any significant difference 
between the success rates for ES and FC pulpotomy techniques 
which is similar to the results of a study by Rivera et al. [54].  
In a randomized clinical trial, Farrokh Gisoure [27] 
compared the clinical and radiographic success rate of ES, FC, 
and FS pulpotomies of primary molars. The overall success 
rates of ES, FC and FS were 83.3, 82.1 and 87.5%, respectively. 
Favorable clinical and radiographic success rates of ES and FS 
pulpotomy was observed which was comparable to FC. 
Because of few clinical trials comparing ES to other 
pulpotomy techniques, further clinical studies must be 
conducted to reveal reliable results toward effectiveness of ES 
pulpotomy in primary teeth.  
 
Table 2. Variable success rates with different direct pulp capping (DPC) agents (FC=formocresol, EMD=enamel matrix derivatives, 
CH=calcium hydroxide) 
Author, year DPC medicament Clinical success (%) Follow-up (month) 
Sample size (n) 
Baseline Final 
Fallahinejad et al. (2013) [55] 
MTA 95 
20 42 38 
CEM 89 
Fallahinejad et al. (2010) [14] 
MTA 100 6 21 19 
CEM 94.8 6 21 19 
Aminabadi et al. (2010) [12] 
FC 90 24 60 - 
CH 61.7 24 60 - 
Garrocho-Rangel et al. (2009) [13] 
EMD 97 12 45 45 
CH 97 12 45 45 
Tuna and Ölmez (2008) [11] 
MTA 100 12 25 22 
CH 100 12 25 22 
Caicedo et al. (2006) [16] MTA 80 6 10 10 
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Laser: Since the early 1960s, lasers have been introduced to 
medicine and dentistry. Different lasers are used in pediatric 
dentistry. These lasers include diagnosis of caries development 
(diode 655 mm), argon lasers for composite curing, Co2 lasers with 
wavelength of 10600 nm for soft tissue surgeries, Nd: YAG lasers 
with wavelength of 1064 nm as well as diode laser with wavelength 
of 810-980 nm for soft tissue cutting, the Erbium laser family 
including Er: YAG (2940 nm) and Er; Cr: YSGG (2780 nm) which 
were used in hard tissues, cavity preparation and in soft tissue 
surgery and also low power lasers which are used in stimulatory 
and inhibitory biologic process [56]. Several studies have revealed 
that laser have proper effects in pulpotomy of primary teeth with 
results similar or even better than FS [20-22]. The advantages of 
laser compared to conventional pulpotomy, such as hemostasis, 
preservation of vital tissues near the tooth apex, absence of 
vibration and odor may lead to satisfaction of children and their 
parents. Nd: YAG laser with output power of 2 W and frequency 
of 20 Hz, Er:YAG laser with power of 0.5 W and frequency of 20 
Hz, Co2 laser and 632/980 nm diode lasers can be used for 
pulpotomy of primary teeth [56-58]. 
Liu et al. [20] in a clinical study compared the effects of Nd: 
YAG laser pulpotomy with FC on human primary teeth. They 
concluded that the success rates of the Nd: YAG laser was 
significantly higher than the FC pulpotomy and the permanent 
successor of laser-treated teeth erupted without any complication. 
Odabas et al. [22] reported that the clinical and 
radiographic success rates of Nd: YAG laser were 85.71 and 
71.42%, respectively which were lower than success rates of FC 
pulpotomy. But there were no significant differences between 
laser and FC pulpotomy. 
Based on a systematic review by De Coster et al. [57], laser 
has less success than conventional pulpotomy techniques and 
general recommendation for the clinical use of laser pulpotomy 
in primary teeth cannot be performed yet. 
Preservation 
In preservation methods, the pulp tissue is only minimally 
insulted. Preservation of pulpal tissue is exemplified by FS and 
NaOCl pulpotomy, which enable retention of maximum vital 
tissue and conservation of the radicular pulp without induction 
of reparative dentine. 
Ferric Sulfate: FS is a coagulative and hemostatic agent which 
is used for pulpotomies of primary teeth. Clinical and 
radiographical success rates for FS pulpotomies which were 
reported in several studies were 88-100% and 74-97%, 
respectively [26, 27, 29, 59-63]. A higher percentage of internal 
resorption is the major failure of FS pulpotomies reported by 
Papagiannoulis [63]. A recent systematic review and meta-
analysis concluded that pulpotomies performed with either FC 
or FS in primary molars have similar clinical and radiographic 
success [64]. Furthermore, FS is inexpensive solution and no 
concerns about toxicity and carcinogenicity of FS have been 
recorded in dental literature [27]. Therefore, FS may be 
recommended as a suitable substitute for FC [64]. Table 3 
represents the results of different studies regarding FS and FC 
pulpotomy.  
Sodium Hypochlorite: NaOCl is the most widely used 
irrigating solution in endodontics due to its antimicrobial 
activity, tissue-dissolving property, detergent action, 
homeostasis and the ability to neutralize toxic products. 
Clinical and radiographic success rate of NaOCl pulpotomy 
were reported to be 100 and 76% respectively [36]. However, 
only few clinical trials evaluated the efficacy of NaOCl as a 
medicament in pulpotomy of primary teeth. A pilot study that 
investigated the use of 5% NaOCl by Vargas et al. [35] showed 
promising results after a 12-month period and a retrospective 
study conducted by Vostatek et al. [65] showed similar results.  
 
Table 3. Clinical and radiographic success rates of the studies comparing ferric sulfate (FS) and formocresol (FC) pulpotomy 
Author, year  
Clinical success N (%) Radiographic success N (%) 
Follow-up (Month) 
Sample size (n) 
FC FS FC FS Baseline Final 
Fei et al. (1991) [59] 26 (96.3) 29 (100) 22 (81) 28 (97) 12 
FC=27 27 
FS=29 29 
Fuks et al. (1997) [60] 31 (83.8) 51 (92.7) 27 (73) 41 (74.5) 35 
FC=37 37 
FS=55 55 
Papagiannoulis (2002) [63] 58 (97.3) 66 (90.3) 47 (78.3) 54 (74) 36 
FC=60 60 
FS=73 73 
Ibrevic and Al-Jame (2003) [26] 78 (97.5) 81 (96.4) 75 (91.7) 77 (93.7) 42-48 
FC=80 80 
FS=84 84 
Huth et al. (2005) [61] 44 (96) 42 (100) 43 (93.4) 42 (100) 24 
FC=50 46 
FS=50 42 
Markovic et al. (2005) [29] 30 (90.9) 33 (89.2) 28 (84.8) 30 (81.1) 18 
FC=34 34 
FS=37 37 
Farrokh Gisoure (2011) [27] 24 (100) 27 (96.4) 21 (87.5) 24 (85.7) 9 
FC=24 24 
FS=28 28 
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The results of a study by Al-Mutairi and Bawazir [66], 
showed that the clinical and radiographic success rate of 5% 
NaOCl pulpotomy were 94.6 and 86.5%, respectively after 12 
months which was comparable to that of FC pulpotomy. 
Ruby et al. [67] compared the clinical and radiographic 
success of vital pulpotomy treatment in primary molars using 
3% NaOCl versus a 1.5 dilute of Buckley’s FC. They reported 
that NaOCl showed 100% clinical success and 90% 
radiographic success and there were no significant differences 
between NaOCl and FC success rates. This finding is in 
accordance with Shabzendedar et al. [68] who reported no 
significant difference between these materials.  
According to the studies mentioned above, it can be 
concluded that the clinical and radiographic success rates for 
NaOCl are comparable to FC pulpotomy in primary teeth but 
more randomized clinical trials must be conducted to conclude 
reliable decisions. 
Regeneration 
Formation of reparative dentine and preservation of healthy 
pulp tissue is rationale of regeneration approach which is done 
by several biomaterials and medicaments mentioned below:  
Calcium hydroxide: CH was introduced to dentistry in 1838 by 
Nygren [69]. In 1930, Hermann showed that CH stimulated the 
formation of new dentin when placed in contact with human 
pulp tissue. Regarding VPT, CH was used as medicament for 
IDPC, DPC and pulpotomy in permanent and primary teeth, 
because of its bactericidal effect and ability to stimulate dentin 
bridge formation [70]. However, there are controversies 
regarding the use of CH in primary teeth pulpotomy, because it 
results in the development of chronic pulpal inflammation and 
internal resorption [71].  
Huth et al. [58] compared the success rates of pulpotomy 
with Er: YAG laser, CH, FS and dilute FC in primary teeth. They 
concluded that after 36 months of follow-up, FS revealed the best  
 
Table 4. Clinical and radiographic success rates of the studies comparing MTA and formocresol (FC) pulpotomy 
Author, year 
Clinical success N (%) Radiographic success N (%) 
Follow-up (Month) 
Sample size (n) 
FC MTA FC MTA Baseline Final 















































































Mettlach et al. (2013) [84] 131 (99) 119 (100) 105 (79) 113 (95) 42 MTA=135 119 
 
IEJ Iranian Endodontic Journal 2015;10(1):6-15 




treatment outcome among the used techniques, while CH 
resulted in the lowest success rates. However, no significant 
differences were detected between FC and any other techniques. 
Markovic et al. [29] found no statistical differences in overall, 
clinical and radiographic success rates for CH, FC and FS 
pulpotomies in their 18-month follow-up study. However, CH 
had the lowest overall success rate among the medicaments. 
Although the cause of the inflammation inducing internal 
resorption is not fully understood, some researchers believed 
that the formation of blood clot following pulpotomy procedure 
interferes with wound healing and induces chronic inflammation 
of the residual pulp [70]. Whereas others have asserted that 
internal resorption leading to pulpal inflammation before 
pulpotomy is an important factor in the failure of CH 
pulpotomies [85]. The clinical success rates of CH pulpotomy of 
primary teeth have ranged between 31 to 100 % [71]. 
Mineral trioxide aggregate: As a member of hydraulic calcium 
silicate cements [31] MTA was introduced by Lee et al. [86] 
and patented in 1995 by Torabinejad and White [87]. MTA 
consists of tricalcium silicate, bismuth oxide, tetra calcium 
alumina-ferrite and calcium-sulphate dehydrate. When MTA is 
mixed with water, a colloid gel with a pH of 12.5 similar to that 
of CH is formed [24]. When MTA was first commercialized, it 
had a gray coloration but in 2002 a new formula was created, 
the white MTA, to improve on the tooth discoloration property 
exhibited by gray MTA. 
The major benefits of MTA are biocompatibility, being 
bactericidal and induction of cementogenesis. Furthermore, 
sealing ability, dentinogenesis and osteogenesis make it the 
preferred choice for numerous clinical treatments such as DPC, 
apexogenesis and apexification in immature teeth [31, 88]. In 
primary teeth, MTA is predominantly used for DPC [11, 16] 
and pulpotomy procedures [48, 89, 90]. The overall success 
rates for MTA as a pulpotomy medicament in primary teeth 
range from 94 to 100 % [31] based upon meta-analysis [91], 
systematic reviews [30] and evidence base assessments [92]. It 
seems that the efficacy of MTA is superior to FC which is the 
gold standard in pulpotomy of deciduous teeth [72, 92]. A huge 
number of investigations about evaluation of clinical and 
radiographic success rates of MTA as a pulpotomy medicament 
in primary teeth were performed. In Table 4, the recent studies 
comparing MTA and FC are mentioned. 
Shirvani et al. [93] also compared the treatment outcomes 
of MTA and CH in a systematic review/meta-analysis and 
revealed that for pulpotomy of vital primary molars, MTA has 
better treatment outcomes compared to CH. 
Calcium-enriched mixture (CEM) cement: CEM cement was 
introduced as an endodontic filling material. The major 
components of the cement powder are calcium oxide (CaO), 
sulfur trioxide (SO3), phosphorus pentoxide (P2O3) and silicon 
dioxide (SiO2). The physical properties of this biomaterial, such 
as flow, film thickness, primary setting time and setting in 
aqueous environments are favorable [94]. 
CEM cement has proper biocompatibility, it can induce hard 
tissue and hydroxyapatite formation and it can resist microbial 
re-entrance and has remarkable antibacterial activity [14]. 
Recently, a 2-year randomized clinical trial study on the 
treatment outcomes of MTA and CEM pulpotomy in primary 
molars was done by Malekafzali et al. [95]. Overall, clinical and 
radiographic success rates in both MTA/CEM groups were 
comparable without any significant differences after 36 months 
of follow-up. Therefore, it seem that CEM may be an effective 
pulp dressing biomaterial [96, 97] but further investigations 
require to confirm the effectiveness of CEM cement for 
pulpotomy of primary teeth. 
Other materials have been also evaluated for pulp capping 
such as BioAggregate, Endosequence Root Repair Material 
(ERRM), Biodentin, and Theracal [98-100]. However, in order 
to reach a definite conclusion about these materials, further 
clinical investigations in primary teeth are needed. 
Discussion 
Primary dentition is essential for arch length maintenance, 
mastication, speech and esthetic in children and preservation 
of primary teeth in an intact condition until eruption of 
permanent successors is critical. Pulp injuries due to caries and 
trauma may threat pulp vitality, so appropriate treatment such 
as IDPC, DPC and pulpotomy must be considered. 
In deciduous teeth, the failure rate of DPC is high and 
according to guidelines of AAPD, DPC is not recommended 
for primary teeth. However, several studies present high 
success rate of DPC treatment with some biomaterials [13, 14]. 
Based on clinical success rates of IPT, which are more than 
90% [5, 6, 8]; this procedure is recommended as a preferable 
method for treating primary teeth with deep caries and 
reversible pulp inflammation. Among different medicaments 
used for IDPC, RMGI presents higher success rate than the 
others [5, 6, 8]. IDPC is less expensive, has fewer potential side 
effects and does not exhibit early tooth exfoliation [7, 101]. 
Pulpotomy is still the most common treatment method in 
case of pulp exposure in symptom-free primary molars, but in 
most cases the success of pulpotomy decreases overtime from 
≥90% during the first 6-12 months to ≤70% after 36 months or 
more [8]. However, among different techniques and 
medicaments used in primary molar pulpotomy, the MTA 
pulpotomy appears to have a higher long-term success rate 
(>90%) [48, 64, 73]. On the other hand almost all of the studies 
on MTA pulpotomy have rather small sample size (n<50) [81] 
and have been done in short duration (<36 months) [78] and 
thus they may not be reliable enough to draw strong conclusions. 
Primary molar pulpotomy has some side effects. Internal 
root resorption is one the most unfavorable outcomes 
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stemming from chronic inflammation of residual radicular 
pulp [102]. This may be attributed to diagnostic errors made 
during assessing pulp condition or to technical failure while 
performing the selective procedure. Furthermore, early 
exfoliation of pulpotomized teeth is another side effect. More 
than 35% of FC pulpotomized teeth exfoliate earlier (≥6 
months) than non pulpotomized teeth [8, 101]. 
Another complication is dentigerous cyst forming in 
permanent successors of pulpotomized deciduous teeth which 
were reported in several studies [103-105]. So, accurate 
diagnosis of pulp status and proper techniques are essential for 
success of pulpotomy and if some doubts about condition of 
pulp exist, the other methods such as pulpectomy or extraction 
must be considered. 
Conclusion 
We can conclude in this literature review that: 
1- IDPC is a favorable technique for treating primary teeth 
with deep caries without exposure of the reversibly 
inflamed pulp; it offers the advantages of lower cost, long-
term higher success rate, and better exfoliation pattern. 
2- DPC has not been recommended for primary teeth until 
now. Some new biomaterials present desirable result but 
long-term evaluation must be considered. 
MTA pulpotomy is the most successful procedure among 
various types of pulpotomy in primary molar, but further 
randomized clinical trials with large sample size and long-term 
follow-up must be conducted. 
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